Delivery Order SPE2DB22D1017-SPE2DB24FG3NR

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3NR
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The order has a ceiling value of $3,518.35 and a completion date of August 20, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen leverages its extensive supply chain to provide a wide range of prescription medications, medical supplies, and equipment to various government agencies, including the military. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal entities, which serve as primary vehicles for supplying critical pharmaceutical and medical commodities to support military treatment programs and other federal healthcare needs nationwide.

Generated 11/18/24, 9:15 AM